Comprehensive Clinical Assessment: Sandhya Dubey, 52F

1. PATIENT PROFILE SUMMARY

2. INVESTIGATION FINDINGS - FULL ANALYSIS

2A. MRI Brain

• Empty Sella - CSF-filled sella, pituitary gland thinned and flattened. Prominence of perineural sleeve around optic nerve bilaterally
• Diffuse Cerebral Atrophy - Prominent cortical sulci, sylvian fissures, bilateral lateral and third ventricles
• Diffuse Cerebellar Atrophy - Subarachnoid cisterns prominent in posterior fossa; fourth ventricle mildly dilated
• Ischemic Demyelination - T2/FLAIR hyperintensities in periventricular white matter, centrum semiovale, and corona radiata bilaterally (no restricted diffusion - so no acute ischemia)
• Chronic Infarcts - Bilateral basal ganglia, thalami, and pons
• Mucosal thickening - Bilateral ethmoid and maxillary sinuses

1. Empty sella with perineural sleeve prominence - Benign Intracranial Hypertension (BIH/IIH) needs consideration
2. Diffuse cerebral and cerebellar atrophy with ischemic demyelination
3. Chronic infarcts in bilateral basal ganglia, thalami, and pons

2B. MRI Cranial & Neck Vessels Angiography (MRA)

• Atheromatous changes in bilateral distal common carotid arteries, carotid bulb, and adjoining cervical segment of bilateral ICA
• Mild stenosis of bilateral ICA (cervical segment)
• Vertebral arteries, basilar artery, intracranial arteries - all normal
• No aneurysm or vascular malformation

2C. MRI Brain Venography

• Mural irregularity in bilateral transverse sinuses and proximal sigmoid sinuses - ? Chronic thrombosis
• Superior sagittal sinus, straight sinus, confluence - normal
• Major cerebral veins - normally visualized

2D. Fundus Photography (Left Eye - OS)

2E. Visual Evoked Potential (VEP) Test

• Normal P100 latency is conventionally <115 ms (interocular difference <10 ms)
• Left eye P100 = 118.8 ms - This is mildly delayed (above the 115 ms upper normal limit)
• Right eye P100 = 112.5 ms - Borderline/within normal range
• Interocular latency difference = 6.3 ms (within the <10 ms normal range)
• Amplitudes are low-normal (5-6 µV range)

2F. Prescription / Medications (Handwritten)

• The patient is on Telmisartan + Amlodipine - appropriate ARB + calcium channel blocker combination for hypertension with diabetes (ARBs are renoprotective in DM)
• Aspirin 75 mg - appropriate antiplatelet given chronic lacunar infarcts and bilateral ICA stenosis
• Atorvastatin 10 mg - appropriate for atheromatous carotid disease; however, the dose (10 mg) is LOW for a patient with demonstrated carotid atherosclerosis + chronic infarcts - consider escalation to 40-80 mg
• Triple DM therapy (Sitagliptin + Metformin + Pioglitazone or Glimepiride combination) - managing her long-standing T2DM
• Caution: Pioglitazone can cause fluid retention and increase intracranial pressure risk, which is relevant given her BIH picture

3. INTEGRATED CLINICAL DIAGNOSIS

PRIMARY DIAGNOSES

• Chronic lacunar infarcts in bilateral basal ganglia, thalami, and pons
• Ischemic white matter demyelination (periventricular, corona radiata)
• Driven by 7 years of hypertension + diabetes + carotid atherosclerosis
• This is the PRIMARY cause of her gait imbalance and posterior heaviness

• Chronic posterior circulation small vessel disease
• Cerebellar atrophy with dilated 4th ventricle and prominent posterior fossa cisterns
• Directly explains her imbalance while walking and vertigo-like symptoms

• Empty sella with perineural optic nerve sleeve prominence
• Mural irregularity in bilateral transverse sinuses (?chronic thrombosis) - can impair CSF drainage
• Mildly delayed left P100 on VEP suggesting optic nerve conduction slowing
• Normal-appearing fundus (no overt papilledema currently, but this does not exclude raised ICP)
• Her obesity (inferred from comorbidity profile), female sex, and age are risk factors
• Contributes to head heaviness, posterior headache, and visual pathway slowing

• Bilateral atheromatous carotid disease
• Driven by DM + hypertension - the underlying substrate for all cerebrovascular findings

SECONDARY / CONTRIBUTING DIAGNOSES

• Can cause neck pain radiating to the posterior head
• Styloid impingement on carotid artery can cause transient hemodynamic changes
• Can contribute to her posterior heaviness and neck-related symptoms
• Importantly, the ICA stenosis found on MRA is at the carotid bulb/cervical segment - this is precisely where Eagle syndrome impinges

• Contributes to posterior head heaviness, nuchal stiffness, and cervicogenic vertigo
• Vertebral artery compression in cervical spondylosis can worsen posterior circulation blood flow
• This interacts with the existing cerebellar atrophy to worsen gait instability

• Joint pain and instability can worsen walking imbalance
• Proprioceptive input from arthritic joints is reduced, compounding the cerebellar and small vessel contributions

4. PATHOPHYSIOLOGICAL EXPLANATION OF SYMPTOMS

5. MEDICATION REVIEW - DETAILED ASSESSMENT

Current Medications:

Medications that should be considered/added:

1. Statin dose escalation - Urgently needed (Atorvastatin 40-80 mg)
2. BP optimization - Ensure target BP is <130/80 mmHg in this high-risk patient
3. HbA1c review - Needs to be checked; if poorly controlled, cognitive decline and cerebellar atrophy will accelerate
4. Anticoagulation review - If the venous sinus mural irregularity represents true chronic thrombosis, anticoagulation (warfarin or NOAC) may be indicated (currently she is only on aspirin)
5. Vitamin B12 - Metformin depletes B12; chronic B12 deficiency can cause subacute combined degeneration worsening gait and balance
6. Vestibular rehabilitation - For cerebellar gait instability
7. Consider Acetazolamide - If BIH is confirmed on CSF pressure measurement (reduces CSF production, helpful in IIH)

6. RECOMMENDED NEXT STEPS

1. Lumbar Puncture (LP) - Opening CSF pressure measurement to confirm/exclude raised ICP and support the BIH/IIH diagnosis
2. Formal ophthalmology referral - Slit lamp, formal visual field testing, and repeat fundus to document any optic disc changes over time
3. Fasting lipid profile + HbA1c - Urgent, to guide statin and DM drug adjustment
4. Serum Vitamin B12 level - Rule out metformin-induced B12 deficiency contributing to neuropathy and balance issues
5. Dedicated MRI cervical spine - Full assessment of cervical spondylosis, cord signal, vertebral artery flow
6. Vestibular function tests (Videonystagmography/VNG) - Differentiate peripheral vs central vestibular component
7. CT Temporal bone - To assess styloid process length for Eagle syndrome
8. Medication reconciliation - Clarify exact Pioglitazone dose (is it in both tablets?) to avoid inadvertent double dosing
9. Neurovascular follow-up - Repeat carotid Doppler in 6 months to monitor stenosis progression

7. SUMMARY

Important Note: This analysis is based on the investigation reports provided and is intended as a clinical educational aid. All treatment decisions must be made by the treating neurologist (Prof. Sunil Pradhan) with direct patient assessment. This does not constitute a substitute for in-person clinical evaluation.

Corrected Medication List for Sandhya Dubey

Dapagliflozin - Detailed Review in This Patient's Context

Mechanism of Action

Why This Drug Is PARTICULARLY BENEFICIAL for This Patient

Important Cautions / Monitoring Points for Dapagliflozin in This Patient

• Glycosuria increases risk of UTIs and genital fungal infections
• Particularly important in a 52-year-old post-menopausal woman
• She should be monitored regularly for UTI symptoms; chronic UTI can worsen her posterior head heaviness and general function

• Rare but serious risk - can occur even with normal blood sugars
• If she is ever kept nil by mouth (surgery, illness), Dapagliflozin should be held 3 days before any procedure

• Glucose-lowering efficacy reduces if eGFR <45 ml/min/1.73m²
• Dapagliflozin is contraindicated below eGFR <25 ml/min/1.73m²
• She must have serum creatinine + eGFR checked regularly given her long-standing DM and hypertension

• Glimepiride (sulfonylurea) + Dapagliflozin together can sometimes cause overcorrection of blood sugar if meals are missed
• Monitor for hypoglycemic episodes - which in her case, with cerebellar atrophy and gait instability, could cause dangerous falls

• The osmotic diuretic effect of Dapagliflozin combined with Amlodipine + Telmisartan may occasionally cause relative volume depletion
• This can transiently worsen cerebral perfusion in a patient with already compromised small vessel disease
• Watch for orthostatic hypotension symptoms which could worsen her imbalance

Overall Updated Medication Assessment

Bottom Line on Dapagliflozin

Disclaimer: This analysis is for clinical educational purposes. All prescribing decisions rest with her treating neurologist/physician (Prof. Sunil Pradhan) based on direct clinical evaluation.This is the actual prescription from SGPGI Neurology. Let me analyze it fully.

Complete Prescription Review - SGPGI Neurology

COMPLETE DECODED MEDICATION LIST

Section 1 - Neurologist's Newly Added / Continued Drugs (Printed + Handwritten)

Section 2 - Pre-existing / Other Physician's Drugs (Continued)

DRUG-BY-DRUG CLINICAL ANALYSIS

1. Preva Gold 20 (Atorvastatin 20mg + Aspirin 75mg) - Bedtime ✅

• Excellent choice for this patient - addresses BOTH her carotid atherosclerosis AND need for antiplatelet therapy in a single tablet
• Atorvastatin taken at bedtime is correct (liver synthesizes cholesterol at night - peak effect at bedtime)
• Previous Unison AS 10mg statin has been appropriately upgraded to 20mg
• Note: For a patient with chronic multi-territory infarcts + carotid stenosis, guidelines recommend high-intensity statin (Atorvastatin 40-80mg). The treating neurologist has moved from 10mg to 20mg - this is better but still in the moderate intensity range. Further dose escalation may be considered after lipid reassessment

2. Limcee 500 (Vitamin C) - Morning ✅

• Antioxidant support for vascular endothelial function
• Helps with collagen synthesis, beneficial in cervical spondylosis and OA
• No significant drug interactions at this dose
• Safe, low-risk addition

3. Shikobion Forte (Benfotiamine + Methylcobalamin + ALA + Folic Acid) - Alternate Day ✅✅

• This is a very well-chosen drug for this patient
• Benfotiamine (fat-soluble B1) - specifically treats diabetic neuropathy and protects neurons from advanced glycation end-products (AGEs)
• Methylcobalamin - active form of B12; Metformin depletes B12 causing peripheral neuropathy and posterior column degeneration (which worsens her balance!)
• Alpha-Lipoic Acid (ALA) - powerful antioxidant, reduces oxidative stress in diabetic neuropathy, crosses blood-brain barrier
• Folic Acid - reduces homocysteine (elevated homocysteine is a risk factor for cerebrovascular disease)
• Given alternate day (not daily) dosing is unusual - likely to balance with Shikbona MG below

4. Shikbona MG (Methylcobalamin + Magnesium) - Alternate Day ✅

• Magnesium plays a role in nerve conduction and muscle function
• Magnesium deficiency is common in T2DM (insulin resistance causes urinary Mg loss)
• Helps with cervical spondylosis-related muscle spasm and nerve pain
• Alternating with Shikobion Forte = patient gets B12 support every day (on alternate days from each drug) - smart prescribing

5. Pirancipil-C (Piracetam + Citicoline) - Twice Daily ✅✅

• This is the key neuroprotective drug addressing her core neurological complaint
• Piracetam - nootropic, improves neuronal membrane fluidity, enhances cerebral blood flow, used in cerebellar ataxia and post-stroke gait disturbance
• Citicoline (CDP-Choline) - neuroprotective, repairs neuronal membranes, increases acetylcholine synthesis, used in cognitive decline + cerebellar dysfunction + post-stroke recovery
• Together: directly targets the cerebellar atrophy and lacunar infarcts causing her gait imbalance
• Well-established use in vascular cognitive impairment in India

6. Diamox 250mg (Acetazolamide) - Twice Daily ✅✅ KEY DRUG

• This is the most important neurologist-specific addition
• Carbonic anhydrase inhibitor - reduces CSF production by ~50% in the choroid plexus
• First-line drug for Idiopathic Intracranial Hypertension (IIH) / BIH - confirmed by the MRI findings of empty sella + perineural sleeve prominence
• Starting dose 250mg BD is appropriate (guidelines recommend 500mg BD as starting dose; this 250mg BD is a gentler initiation - likely chosen because she has multiple comorbidities)
• The neurologist has correctly identified and treated the BIH component
• Explains her posterior head heaviness and VEP delayed latency

• Serum electrolytes (causes hypokalemia + metabolic acidosis)
• Serum bicarbonate
• Renal function (carbonic anhydrase inhibitor - affects kidneys)
• Avoid if sulfa allergy (cross-reactivity)
• May cause tingling in fingers/toes (paresthesia) - a benign but common side effect she should be warned about

7. Rozucor 10 (Rosuvastatin 10mg) - Once Daily ⚠️ DUPLICATION CONCERN

• IMPORTANT FLAG: She is now on BOTH Atorvastatin 20mg (in Preva Gold) AND Rosuvastatin 10mg (Rozucor)
• This represents a dual statin prescription - this needs clarification
• Two statins together are NOT standard practice and increase the risk of myopathy and rhabdomyolysis
• Possible explanation: Rozucor 10 may be from a previous prescription (diabetologist/physician) that has not been stopped, while Preva Gold is the neurologist's addition
• Action needed: Clarify with the treating team - only one statin should be taken
• If combined intent was high-intensity, better to simply escalate to Atorvastatin 40mg or Rosuvastatin 20mg alone

8. Gluconorm G2 Forte (Glibenclamide 2mg + Metformin 500mg) ✅

• Appropriate dual DM therapy
• Glibenclamide (sulfonylurea) - stimulates insulin secretion
• Combined with Metformin - works synergistically
• Caution: Glibenclamide has the highest hypoglycemia risk among sulfonylureas - she should eat meals on time; hypoglycemia + cerebellar ataxia = serious fall risk

9. Tenagliptin/Teneligliptin 20mg (DPP-4 inhibitor) ✅

• Well-tolerated DPP-4 inhibitor
• No hypoglycemia when used alone
• Caution: Avoid in patients with severe renal impairment
• Safe addition to her DM regimen

10. Telma-AM (Telmisartan 40mg + Amlodipine 5mg) ✅✅

• Excellent combination for a hypertensive diabetic with cerebrovascular disease
• Telmisartan (ARB) - renoprotective, reduces diabetic nephropathy progression
• Amlodipine (CCB) - smooth cerebral vasodilation, beneficial in patients with carotid disease
• Together provide good 24-hour BP coverage

11. Atenolol 25mg ⚠️ CAUTION - Review Needed

• Beta-1 blocker for hypertension
• Concerns in this patient:
  • Atenolol masks hypoglycemia symptoms (sweating, palpitations) - she is on Glibenclamide which CAN cause hypoglycemia - this masking is dangerous
  • Atenolol can cause fatigue and exercise intolerance - already has balance issues and needs vestibular rehabilitation - this drug may hinder rehab effort
  • Some evidence suggests atenolol is less effective than other antihypertensives in preventing stroke recurrence compared to ARBs/CCBs (she already has Telma-AM)
  • Question: Is this needed given she already has Telmisartan + Amlodipine? If added for rate control or persistent uncontrolled BP, a low dose is acceptable - but the interaction with Glibenclamide-induced hypoglycemia masking must be discussed with the treating physician

OVERALL POLYPHARMACY ASSESSMENT

KEY CONCERNS SUMMARY

OVERALL IMPRESSION

Disclaimer: This review is for clinical educational purposes only. Medication decisions must be made by the treating physicians at SGPGI.

Gastric Content Coming Into Mouth - Clinical Analysis

What Is This Symptom Exactly?

IS IT CONNECTED TO HER BRAIN OR IS IT PURELY GASTRIC?

CAUSE 1: RAISED INTRACRANIAL PRESSURE (IIH) - DIRECT BRAIN CONNECTION 🧠

• The brainstem vomiting centre (area postrema in the medulla oblongata) gets directly stimulated by the raised pressure
• This causes nausea, vomiting, and regurgitation - NOT from any stomach problem - it is centrally triggered
• Classic teaching: ICP-related vomiting is "projectile," without preceding nausea, not related to food - but in chronic low-grade IIH, it often manifests as persistent nausea and acid-coming-up rather than frank vomiting
• She also has chronic infarcts in the pons and brainstem region - the pons contains centres that modulate gastrointestinal motility. Brainstem damage = impaired GI coordination
• As per Yamada's Gastroenterology textbook, "Central nervous system disorders: brainstem lesions" are listed as a direct cause of gastroparesis

CAUSE 2: DIABETIC GASTROPARESIS / AUTONOMIC NEUROPATHY - DIABETES CONNECTION 🩺

• Diabetic autonomic neuropathy affects the vagus nerve (the main nerve controlling gastric emptying)
• This leads to delayed gastric emptying (gastroparesis) - food and acid sit in the stomach too long
• The stomach becomes overfull, pressure builds, and acid regurgitates upward into the oesophagus and mouth
• Prevalence of delayed gastric emptying in Type 2 DM = 10-20% of long-standing patients
• Associated with other autonomic features she may have: orthostatic dizziness (contributing to her imbalance!), constipation, urinary changes

CAUSE 3: DRUG-INDUCED - MULTIPLE MEDICATIONS ⚠️

• It was started approximately 15 days ago
• The patient's new symptom started 15 days ago
• This temporal correlation is highly suspicious
• Diamox causes metabolic acidosis by wasting bicarbonate - the body becomes more acidic, promoting acid production and worsening lower oesophageal sphincter tone
• Many IIH patients on Diamox report acid reflux and heartburn as a troublesome side effect

CAUSE 4: MECHANICAL / POSITIONAL FACTORS 🔄

• She has cervical spondylosis - the abnormal neck posture and muscle tension can impair normal swallowing mechanics and oesophageal clearance
• Eagle syndrome (elongated styloid process) - the styloid can press on the internal carotid, pharyngeal muscles, and glossopharyngeal nerve, potentially affecting swallowing and the sensation of something coming up
• Obesity (likely given her BIH risk profile) increases intra-abdominal pressure and pushes acid upward
• Osteoarthritis may limit her mobility - prolonged sitting or lying after meals encourages reflux

SUMMARY DIAGRAM - All Contributing Factors

GASTRIC CONTENT IN MOUTH
         │
    ┌────┴─────┐──────────────┐──────────────┐
    ↓          ↓              ↓              ↓
BRAIN/ICP  DIABETIC      DRUG-INDUCED   MECHANICAL
CAUSE      GASTROPARESIS  (DIAMOX,       (Cervical
           (Autonomic     Aspirin,       Spondylosis,
Brainstem  Neuropathy,    Metformin,     Eagle Syn,
Vomiting   7yr DM)       Piracetam,     Obesity)
Centre                    ALA)
stimulated
by BIH

WHAT SHOULD BE DONE NOW?

Immediate Steps:

• Start Tab Pantoprazole 40mg or Rabeprazole 20mg - once daily, 30 minutes before breakfast
• This will reduce acid production, protect the oesophagus, and counteract Aspirin-induced gastric irritation
• Also protects against Aspirin-induced peptic ulcer (she is on long-term aspirin)

• Diamox (acetazolamide) should be taken with meals to reduce GI irritation
• If symptoms persist, the neurologist may need to adjust the dose or timing

• Never on empty stomach - this is a common cause of ALA-related reflux

• Small, frequent meals (5-6 small meals rather than 3 large ones) - helps gastroparesis
• Do NOT lie down for at least 2 hours after eating
• Elevate head end of bed by 30 degrees at night
• Avoid spicy, oily food, tea/coffee, carbonated drinks
• Avoid eating right before bedtime

• Hyperglycemia worsens gastroparesis - her HbA1c needs to be checked
• Better sugar control = better gastric motility

• If acid coming up does not resolve within 2-4 weeks after starting PPI, a gastric emptying study should be done to formally diagnose/exclude gastroparesis
• Upper GI endoscopy may be needed to rule out oesophagitis or peptic ulcer (especially given long-term aspirin use)

BOTTOM LINE

This assessment is for educational clinical discussion. The treating physician at SGPGI should review and prescribe accordingly.